Publication

Article

Pharmacy Times

Volume00

Study Identifies Gene for Ovarian Cancer

An excess of the Rsf-1 gene may play an important role in the development of ovariancancer, based on an analysis of tissue from 7 ovarian cancer samples. Using a digital karyotypingtechnique to identify "subchromosomal alterations," the researchers observed anoverproduction of the Rsf-1 gene located on chromosome 11 in 13.2% of the most aggressiveforms of ovarian cancer. These results were not seen in any of the low-grade ovariancancers.

Because this was the first study to identify this genetic alteration, the new finding maylead to the development of a drug to block the activity of Rsf-1 and therefore stop the cancerouscell growth, concluded senior researcher Tian-Li Wang, PhD, in the Proceedings ofthe National Academy of Sciences (September 27, 2005).

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs